Prostate Cancer Clinical Trial

Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)

Summary

Dosimetry efficacy of the hydrogel spacer.

View Full Description

Full Description

Single arm study for evaluation of dosimetry following use of a commercially available hydrogel spacer implanted in up to 20 males who underwent radiotherapy treatment for prostate cancer. Study utilized pre and post gel insertion CT images to determine endpoints.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Males
At least 18 years of age
Undergone external beam or brachy radiation therapy with a hydrogel spacer in place

Exclusion Criteria:

Clinical and pathological data are not available
Invasive adenocarcinoma that is extracapsular and demonstrates posterior extension

Study is for people with:

Prostate Cancer

Estimated Enrollment:

19

Study ID:

NCT05423431

Recruitment Status:

Completed

Sponsor:

BioProtect

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Advanced Radiation Centers of New York ("ARC")
Lake Success New York, 11104, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

19

Study ID:

NCT05423431

Recruitment Status:

Completed

Sponsor:


BioProtect

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider